Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ana López de la Guía"'
Autor:
Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, Laura Rosiñol, María-Jesús Blanchard, José-María Bellón, Ramón García-Sanz, Javier de la Rubia, Ana López de la Guía, Ana Jímenez-Ubieto, Isidro Jarque, Belén Iñigo, Victoria Dourdil, Felipe de Arriba, Clara Cuéllar Pérez-Ávila, Yolanda Gonzalez, Miguel-Teodoro Hernández, Joan Bargay, Miguel Granell, Paula Rodríguez-Otero, Maialen Silvent, Carmen Cabrera, Rafael Rios, Adrián Alegre, Mercedes Gironella, Marta-Sonia Gonzalez, Anna Sureda, Antonia Sampol, Enrique M. Ocio, Isabel Krsnik, Antonio García, Aránzazu García-Mateo, Joan-Alfons Soler, Jesús Martín, José-María Arguiñano, María-Victoria Mateos, Joan Bladé, Jesús F. San-Miguel, Juan-José Lahuerta, Joaquín Martínez-López, GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-8 (2022)
Abstract Infections remain a common complication in patients with multiple myeloma (MM) and are associated with morbidity and mortality. A risk score to predict the probability of early severe infection could help to identify the patients that would
Externí odkaz:
https://doaj.org/article/fcb4c3d2e7254e4d93afeee7eb8db18a
Autor:
Silvia Sánchez-Ramón, Arancha Bermúdez, Luis Ignacio González-Granado, Carlos Rodríguez-Gallego, Ana Sastre, Pere Soler-Palacín, the ID-Signal Onco-Haematology Group, Luis Allende, Laia Alsina, Ana María Bielsa, Sara Calleja-Antolín, Carmen Cámara, Javier Carbone, Carmen Carreras, Ana De Andrés Martín, Angela Deyá, Cristina Díaz de Heredia, Romina Dieli-Crimi, José Luis Díez, Nerea Domínguez-Pinilla, Luis Fernández-Pereira, José Mᵃ García, Juana Gil-Herrera, Antonio Gutiérrez, Isidro Jarque, Manel Juan, Francisco Lendínez, Pilar Llobet, Mónica López, Ana López de la Guía, Marcos López-Hoyos, Andrea Martín-Nalda, Mónica Martínez, Josefa Melero, Ana Méndez-Echevarría, Pedro Moral, Olaf Neth, María Núñez, Gonzalo Ocejo-Vinyals, Juliana Ochoa-Grullón, Peter Olbrich, Raquel Oña, Manuel Pérez-Encinas, Jaime Pons, Carmen Rodríguez, Berta Sánchez, Juan Luis Santos-Pérez, Mᵃ Elena Seoane, Alexandru Vlagea
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological manifestations, such as peripheral cytopenias or lymphoproliferative syndromes. Early diagnosis and management have signific
Externí odkaz:
https://doaj.org/article/4568dfcd26f44d75b61bebce1b8efe6a
Autor:
Eduardo García Pérez, Raquel de Paz Arias, Beatriz de la Cruz Benito, Patricia Baltasar Tello, Abel Dos Santos Ortas, Victor Jiménez Yuste, Irene Sánchez Vadillo, Andres Lopez, Ana López de la Guía, Karem Humala Barbier, Paula Lázaro del Campo, Mercedes Gasior Kabat, Teresa de Soto Álvarez, Miguel Ángel Canales Albendea
Publikováno v:
Expert Review of Hematology
Spain is one of the countries most strongly affected by the coronavirus (COVID-19) pandemic with more than 800,000 cases reported in the country as of October 5 [1]. In Madrid, the first reported c...
Autor:
Abel Dos Santos-Ortas, Ana López de la Guía, Víctor Jiménez-Yuste, Miguel Ángel Canales-Albendea, Teresa de Soto-Álvarez, Andrés Ramírez-López, Irene Sánchez-Vadillo, Gema Casado-Abad, Paula Lázaro del Campo, Karem Humala-Barbier, Eduardo García-Pérez, Beatriz de la Cruz-Benito
Publikováno v:
British Journal of Haematology
The COVID‐19 pandemic has dramatically challenged care for cancer patients, especially those with active treatment that represent a vulnerable population for SARS‐CoV‐2 infection. Aggressive lymphoid neoplasms, such as diffuse large B‐cell ly
Publikováno v:
Current treatment options in oncologyReferences and Recommended ReadingPapers of particular interest, published recently, have been highlighted as: •• Of major importance. 22(6)
Hematopoietic stem cell transplantation (HSCT) is considered, since 1957, a potentially curative therapeutic option for many hemopathies. Although it is an aggressive procedure, improvements in transplantation techniques and supportive strategies hav
Autor:
Laura Rosiñol, Miguel T. Hernandez, A. Oriol, David Moreno, María Luisa Martin Ramos, Ana Isabel Teruel, Yolanda González, Maria-Victoria Mateos, Luis Palomera, Rafael Rios, María José Calasanz, Javier de la Rubia, Felipe de Arriba, Norma C. Gutiérrez, Antonia Sampol Mayol, Miquel Granell, Juan José Lahuerta, Belén Iñigo, Jesús F. San-Miguel, Ana López de la Guía, Anna Sureda, J. Bladé
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S134-S135
Background t(11;14) is the most frequently IgH rearrengement in newly diagnosed multiple myeloma (NDMM) with a 15-20% prevalence and is considered a standard-risk cytogenetic abnormality (SR). However, t(11;14) is controversial since recent reports d
Autor:
Jesús F. San-Miguel, Joan Bladé, Lucía García Tomás, Maria Dunia De Miguel, Maria-Victoria Mateos, Jose Alonso, Javier Alberto Rojas, Esther González Garcia, Ana López de la Guía, María Jesús Blanchard, Nieves López-Muñoz, Javier de la Cruz, Jose Angel Hernandez-Rivas, Adrian Alegre, Noemi Fernandez-Escalada, Belén Iñigo, Diego Conde Royo, F. Javier Penalver, Fernando Escalante Barrigón, Pilar Bravo Barahona, Laura Rosiñol, Joaquin Martinez-Lopez, Maria Alicia Senin Magan, Cristina Encinas, Juan José Lahuerta, Javier de la Rubia, Anna Sureda
Publikováno v:
Blood
Introduction In the first weeks of the Covid-19 pandemic when healthcare systems in many areas were overstretched, we documented that hospital mortality in multiple myeloma (MM) patients infected by Sars-Cov-2 was 50% higher than in age matched Covid
Autor:
Ana López de la Guía, David Bueno, Irene García García, Francisco Abad-Santos, Elena Ramírez García, Antonio J. Carcas, Jesús Frías Iniesta, Cristina Anton, Rafael de la Cámara, Miriam Estébanez, Gina Mejía, Jaime Monserrat Villatoro, Alberto M. Borobia, María José Otero
Publikováno v:
BMJ Open
IntroductionInvasive aspergillosis is the most important cause of morbidity and mortality in patients with haematological diseases. At present, voriconazole is the first-line treatment for invasive fungal disease. The pharmacokinetic interindividual
Autor:
Jose Luis Sanchez-Majano Suarez-Llanos, Rafael Ríos Tamayo, Maria-Victoria Mateos, Antonio Garcia Guiñon, Miriam Gonzalez Pardo, Carolina Leiva Farre, Mario Arnao Herraiz, Sebastian Garzon Lopez, Juan Alfons Soler, abel domingo garcía, Javier de la Rubia, Ana López de la Guía
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e147
Autor:
M Jesús Blanchard, Maria Luisa Martin-Ramos, Miquel Granell, Norma C. Gutiérrez, Rafael Martínez-Martínez, Antonia Sampol, Jesús F. San-Miguel, Miguel T. Hernandez, Maria-Victoria Mateos, Yolanda Gonzalez-Montes, Joaquin Martinez-Lopez, Luis Palomera, Ana Isabel Teruel, María Teresa Cibeira, Adrian Alegre, Albert Oriol, Isidro Jarque, Laura Rosinol Dachs, Juan José Lahuerta, Felipe de Arriba, Enrique García Bengoechea, Ana López de la Guía, Joan Bladé
Publikováno v:
Blood. 132:126-126
Background: The randomized PETHEMA/GEM phase III trial GEM05menos65 (www.clinicaltrials.gov NCT00461747) demonstrated that pretransplant induction therapy with VTD resulted in a significantly higher CR rate both, pretransplant and postransplant and i